Pyridostigmine Bromide (PB) Pills

What Pyridostigmine bromide (PB pills) is

• A reversible cholinesterase inhibitor intended to pretreat against the nerve agent soman.
• Issued as small white tablets in foil blister packs taken every 8 hours during the threat period.
• Compliance was high — taking PB was a lawful order under the Investigational New Drug authorization.
• Synergistic toxicity has been hypothesized when PB was combined with permethrin (uniform treatment), DEET (skin repellent), and low-level sarin exposure.

Who was exposed

• U.S. service members deployed to the Southwest Asia theater during Operations Desert Shield and Desert Storm.
• Highest exposure: ground combat and forward-deployed units (XVIII Airborne, VII Corps, USMC ground units).
• Documented in unit logs and individual medical records of the period.

Recognized conditions & VA framework

• PB exposure is part of the broader Gulf War Illness presumption under 38 CFR § 3.317.
• Undiagnosed chronic multisymptom illness (fatigue, cognitive, musculoskeletal, GI) — presumptive for qualifying Gulf War veterans.
• MUCMI diagnoses (fibromyalgia, chronic fatigue syndrome, functional GI disorders) — listed § 3.317 presumptives.
• Direct claims for peripheral neuropathy, cognitive dysfunction, and chronic GI symptoms tied to documented PB exposure.

Evidence to gather

• DD-214 establishing Southwest Asia service between August 2, 1990 and the present.
• Treating-provider documentation of chronic symptoms persisting 6+ months.
• Symptom log capturing fatigue, cognitive, GI, and musculoskeletal patterns.
• Unit records or buddy statements confirming PB was issued and taken.
• Nexus opinion for direct claims that fall outside § 3.317 presumptions.

Claim path

1. For Gulf War veterans with chronic multisymptom illness, file under 38 CFR § 3.317 — the cleanest path.
2. Cite the § 3.317 presumption expressly on VA Form 21-526EZ.
3. For specific diagnosed conditions outside § 3.317 (e.g., peripheral neuropathy), file as direct service connection with a nexus opinion citing PB.

Authoritative reference

VA Public Health publishes its own overview of this exposure. Use it as a citation in your claim narrative: https://www.publichealth.va.gov/exposures/gulfwar/sources/pyridostigmine-bromide.asp

Where these claims break down

• ×Filing for 'Gulf War Illness' generically rather than identifying each symptom cluster so each can be rated.
• ×Forgetting to cite § 3.317 — adjudicators sometimes default to direct service-connection rules.
• ×Missing the December 31, 2026 symptom-manifestation deadline (subject to extension).

Frequently Asked Questions